news.google.com· FiercePharma·· 19 hours agoPickScore57
Alcon ponies up $550M for Neurotech, bagging approved cell therapy implant Encelto - Fierce Pharma
Alcon ponies up $550M for Neurotech, bagging approved cell therapy implant Encelto - Fierce Pharma
In brief
Alcon has acquired Neurotech for $550 million, gaining the approved cell therapy implant Encelto.
Why it matters
The $550M acquisition of Neurotech, whose Encelto implant is already approved, offers a direct benchmark for deal sizes of cell therapy assets at the approved stage.
Source: news.google.com · news.google.com